IPO Calendar
Lead Manager
- J P Morgan Chase (490)
- Goldman Sachs (463)
- Morgan Stanley (421)
- Bank of America Merrill Lynch (358)
- Citigroup (222)
- Jefferies (214)
- Credit Suisse (180)
- Barclays (151)
- Cowen and Company (147)
- Deutsche Bank (84)
- Leerink Partners (70)
- Piper Jaffray (70)
- Stifel (65)
- UBS Investment Bank (53)
- Evercore (52)
- RBC Capital (51)
- BMO Capital (49)
- Wells Fargo (47)
- Raymond James (38)
- William Blair (37)
More +
IPO - Pricing (7)
Cantor Fitzgerald
| UnderWriters* | |||||||||||
| Date | Company Name | Sector | Price ($) |
Size (M) |
1 | 2 | 3 | Rank | Turnover | Gain | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 16 | Bionomics Limit | Health-Care | 12.4 | 1 | WB | CNTR | 11.3% | 19.3% | |||
| Dec 3 | Bioplus Acquisi | Finance | 10 | 20 | CNTR | 71.4% | 0.1% | ||||
| Oct 14 | Lucid Diagnosti | Health-Care | 14 | 5 | CNTR | CNCD | 100.3% | -16% | |||
| Oct 7 | THESEUS Pharmac | Health-Care | 16 | 10 | JEFF | SVB | CNTR | 38.9% | 16.1% | ||
| Jul 30 | Rani Therapeuti | Health-Care | 11 | 6 | BAML | Stifel | CNTR | 14.6% | 0% | ||
| Jul 2 | NYXOAH SA | Health-Care | 30 | 2 | PS | Stifel | CNTR | 6.4% | 0.4% | ||
| Feb 12 | NexImmune Inc. | Health-Care | 17 | 6 | BRCL | CNTR | RAYJ | 53.5% | 49% | ||
*
Lead manager or one of top three managers in an underwriting team.